Multi-omics data integration identifies novel biomarkers and patient subgroups in inflammatory bowel disease - Top-Institutions - MDSpire

Multi-omics data integration identifies novel biomarkers and patient subgroups in inflammatory bowel disease

  • By

  • António José Preto

  • Shaurya Chanana

  • Daniel Ence

  • Matthew D Healy

  • Daniel Domingo-Fernández

  • Kiana A West

  • January 4, 2025

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mount Sinai Health System
    Mount Sinai Health System

    New York, NY

    Key Differentiators

    • Gastroenterology
    • Immunology
    • Genomics
    • Bioinformatics

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Genomics

  • #3

    University of California, San Diego (UCSD)
    University of California, San Diego (UCSD)

    San Diego, CA

    Key Differentiators

    • Gastroenterology
    • Microbiome Research
    • Systems Biology

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Gastroenterology
    • Inflammation Research
    • Proteomics

  • #5

    Broad Institute of MIT and Harvard
    Broad Institute of MIT and Harvard

    Cambridge, MA

    Key Differentiators

    • Genomics
    • Computational Biology
    • Multi-omics Integration

Original Source(s)

Multi-omics data integration identifies novel biomarkers and patient subgroups in inflammatory bowel disease

  • by António José Preto, Shaurya Chanana, Daniel Ence, Matthew D Healy, Daniel Domingo-Fernández, Kiana A West

  • January 4, 2025

Related Content

Macrophage dysregulation in inflammatory bowel disease: cellular heterogeneity, pathogenic mechanism, and treatment

Urologic malignancy risk with chronic tumor necrosis factor-alpha inhibitor (TNF-I) exposure: a multicenter, retrospective cohort study

Integrating Double-Balloon Enteroscopy into the Diagnostic Pathway for Suspected Small Bowel Crohn’s Disease: A Retrospective Study from a Tertiary Care Center